Jardiance® (empagliflozin) approved in the EU for the t

'A significant milestone in the field of chronic kidney disease' The European Commission (EC) approved Jardiance® (empagliflozin) for the treatment of

Related Keywords

, Daniel Gallego , Eli Lilly , Carinne Brouillon , Boehringer Ingelheim , Diabetes Obesity Global Medical Affairs , European Kidney Patient Federation , European Commission , European Kidney Patient , Human Pharma , Leonard Glass , Obesity Global Medical Affairs ,